SCHEMBL9050449

SCHEMBL9050449

CCOC(OCC)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)C1Cc2ccccc2C1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PREP P48147 14/20 0.51
F2 P00734 1/20 0.44
CPT2 P23786 1/20 0.38
CPT1A P50416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9050454 1.00 PREP (0.51) PREPF2CPT2CPT1A
SCHEMBL9050560 0.95 F2 (0.51) PREPF2CPT2CPT1A
SCHEMBL9048437 0.95 F2 (0.51) PREPF2CPT2CPT1A
SCHEMBL9048441 0.95 F2 (0.51) PREPF2CPT2CPT1A
SCHEMBL9050551 0.95 F2 (0.51) PREPF2CPT2CPT1A
SCHEMBL9050198 0.88 PREP (0.55) PREPF2
SCHEMBL9047963 0.88 PREP (0.62) PREPF2
SCHEMBL9047977 0.88 PREP (0.62) PREPF2
SCHEMBL9047047 0.86 PREP (0.63) PREP
SCHEMBL9047054 0.86 PREP (0.63) PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed